Delivery Order SPE2DB22D1106-SPE2DB25FEVR9
Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,316.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclophosphamide 1 gm/5 ml vials, a pharmaceutical product used in the treatment of various medical conditions. The contract is a firm fixed-price delivery order with a performance period extending through May 14, 2025. The contract is not set-aside and was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,553.88, is for the delivery of 4,568,075,876 units of the drug Cyclophosphamide 500 mg vials. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime...
- This federal contract award to Amerisourcebergen Drug Corp is for the delivery of 4,566,110,527 units of Cyclophosphamide 2 GM vials. The contract has a ceiling value of $1,538.96 and is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cyclophosphamide 500 mg/2.5 ml vials. The $1,557.60 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of November 29, 2024. The contract was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclophosphamide 2 gm/10 ml vials. The contract has a ceiling value of $3,053.00 and a completion date of June 23, 2025. It is a firm-fixed-price contract and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2 gram vials of the medication Cyclophosphamide, with a ceiling value of $8,983.68 and a period of performance through June 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $77,013.02 firm fixed price contract is for the supply of 4,565,682,849 vials of the chemotherapy drug cyclophosphamide. The award is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025 that provides a comprehensive range of medical commodities to support military treatment programs and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,731.28, is for the delivery of Cyclophosphamide 1 GM/5 ML VL 5ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 26, 2025. This contract is not designated with a set-aside requirement, indicating open...
- This is a $14,611.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,323,995 vials of the pharmaceutical Cyclophosphamide 1 GM. The contract has a completion date of January 16, 2024 and was awarded on January 12, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceuticals, medical...
- This federal contract award is for the delivery of Cyclophosphamide 500 mg vials, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,219.04 and an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...